Search
NEWS

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

By A Mystery Man Writer

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Automated next-generation profiling of genomic alterations in human cancers

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Somatic mutations in facial skin from countries of contrasting skin cancer risk

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types – A one research lab re-evaluation - Computational and Structural Biotechnology Journal

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Frontiers Associations of chest X-ray trajectories, smoking, and the risk of lung cancer in two population-based cohort studies

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Frontiers Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Frontiers Identification of stromal cell proportion-related genes in the breast cancer tumor microenvironment using CorDelSFS feature selection: implications for tumor progression and prognosis

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Epigenetics - Wikipedia

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Patterns of somatic structural variation in human cancer genomes

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer - Frontiers

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

/genes/genes-14-00486/article_deploy/h